Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and Etoposide

Overview of attention for article published in New England Journal of Medicine, January 1999

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 1 news outlet
blogs: 1 blog
policy: 1 policy source
twitter: 8 X users

patent: 5 patents
wikipedia: 2 Wikipedia pages
guideline: 16 clinical guideline sources

Readers on

mendeley: 456 Mendeley

So far, Altmetric has seen 1 policy document that references this research output.

Lung cancer: diagnosis and management : F: Most clinically and cost-effective regimen of chemoradiotherapy for people with limited-stage SCLC

Cited by National Institute for Health and Care Excellence (NICE) on 18 Apr 2019

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.